Development of a stability-indicating HPLC method for the determination of montelukast in tablets and human plasma and its applications to pharmacokinetic and stability studies

Saudi Pharmaceutical Journal

Volumn 12, Issue 4, 2004, Pages 136-143

  Alsarra, Ibrahim A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

HPLC; Montelukast; Pharmacokinetics; Photodegradation study; Stability indicating assay

Indexed keywords

ACETONITRILE; FLUFENAMIC ACID; METHANOL; MONTELUKAST; PHOSPHORIC ACID; POTASSIUM DIHYDROGEN PHOSPHATE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGRADATION KINETICS; DRUG DEGRADATION; DRUG DETERMINATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIGHT EXPOSURE; MALE; NONHUMAN; PHOTODEGRADATION; PLASMA; QUANTITATIVE ANALYSIS; RABBIT; REPRODUCIBILITY; SPECTROPHOTOMETRY; TABLET; VALIDATION PROCESS;

EID: 11144284585     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Riccioni G, Vecchia RD, D'Orazio N, Sensi S and Guagnano MT. Comparison of montelukast and budesonide on bronchial reactivity in subjects with mild-moderate persistent asthma. Pulm Pharmacol Ther 2003;16:111-4.
2. Simons FE, Villa JR, Lee BW, Teper AM, Lyttle B, ristizabal G, Laessing W, Schuster A, Perez-Frias J, Sekerel BE, Menten J and Leff JA. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blinded, crossover study. J Pediatr 2001;138:694-8.
3. Claesson HE and Dahlén SE. Asthma and leukotrienes: ntileukotrienes as novel anti-asthmatic drugs. J Inter Med 1999;245:205-27.
4. Valacer DJ. New treatments for asthma: the role of leukotriene modifier agents. J Natl Med Assoc 1999;91:26S-39S.
5. Amin RD, Cheng H and Rogers JD. Determination of MK-0476 in human plasma by liquid chromatography. J Pharm Biomed Anal 1995;13:155-8.
6. Liu L, Cheng H, Zhao JJ and Rogers JD. Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching, J Pharm Biomed Anal 1997;15:631-8.
7. Ochiai H, Uchiyama N, Takano T, Hara K and Kamei T. Determination of montelukast sodium in human plasma by column-switching high performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Appl 1998;713:409-14.
8. Kitchen CJ, Wang AQ, Musson DG, Yang AY, Fisher AL. A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection. J Pharm Biomed Anal 2003;31:647-54.
9. Radhakrishna T, Narasaraju A, Ramakrishna M and Satyanarayana A. Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods. J Pharm Biomed Anal 2003;31:359-68.
10. Hoang TH, Farkas, R, Wells C, McCliutock and Maso, MD. Application of pressurized liquid extraction technology to pharmaceutical solid dosage forms. J Chromatogr A 2002;968:257-61.
11. Migoya E, Kearns GL, Hartford A, Zhao J, van Aldlsberg J, Tozzi CA, Knoee B and Dutsh P. Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old. J Clin Pharmacol. 2004;44:487-94.
12. Friesen CA, Kearns GL, Andre L, Neustrom M, Roberts CC and Abdel-Rahman SM. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr. 2004;38:343-51.
13. Graff GR, Weber A, Wessler-Starman D and Smith AL. Montelukast pharmacokinetics in cystic fibrosis. J Pediatr. 2003;142:53-6.
14. Knorr B, Nguyen HH, Kearns GL, Villaran C, Boza ML, Reiss TF, Rogers JD, Zhang J, Larson P and Spielberg S. Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults. J Clin Pharmacol. 2001;41:612-9.
15. Zhao JJ, Rogers JD, Holland SD, Larson P, Amin RD, Haesen R, Freeman A, Seing M, Merz M and Cheng H. Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers. Biopharm Drug Dispos. 1997;18:769-77.
16. Kolm G, Zappe H, Scmid R, Riedelberger K and van den Hoven R. Efficacy of montelukast in the treatment of chronic obstructive pulmonary diseases in five horses. Vet Rec. 2003;152:804-6.
17. nd ed. New York; Marcel Dekker, 1982.
18. th ed. New York; John Wiley & Sons, 1994.
19. Cheng H, Leff JA, Amin R, Gertz BJ, De Smet M, Noonan N, Malbecq W and Somers G. Pharmacokinetics, bioavailability and safety of montelukast sodium (MK- 0476) in healthy males and females. Pharm Res 1996;13:445-8.
20. rd ed. New York; Marcel Dekker, 1997.